Page last updated: 2024-10-30

methadone and Cardiac Conduction Defect

methadone has been researched along with Cardiac Conduction Defect in 1 studies

Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.

Research Excerpts

ExcerptRelevanceReference
"Methadone dose/weight was moderately correlated with QTc, and independently associated with longer QTc at both 440 and 470 cut-offs."1.43Methadone maintenance dose/weight ratio, long QTc, and EKG screening. ( Adabag, S; Anand, V; Batres-Y-Carr, T; Thuras, P; Westermeyer, J; Yoon, G, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Westermeyer, J1
Adabag, S1
Anand, V1
Thuras, P1
Yoon, G1
Batres-Y-Carr, T1

Other Studies

1 other study available for methadone and Cardiac Conduction Defect

ArticleYear
Methadone maintenance dose/weight ratio, long QTc, and EKG screening.
    The American journal on addictions, 2016, Volume: 25, Issue:6

    Topics: Adult; Body Weight; Brugada Syndrome; Cardiac Conduction System Disease; Dose-Response Relationship,

2016